EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

A study on appropriate use and stewardship of proton pump inhibitors

Naresh Mondal, Shilpi Maity, Alamki Phawa, Bireswar Roy, E. Satheesh Kumar, Narayana Swamy V.B

Indian Journal of Pharmacy and Pharmacology · 28.05.2024 · 11 (1) · 56-61

DOI: 10.18231/j.ijpp.2024.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmacy and Pharmacology, online erschienen am 15.05.2024. Verfasst von Naresh Mondal und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze the prescribing pattern of use of PPI with respect to “FDA-Approved Indications and Doses for PPI Therapy.” Materials and Methods: After obtaining approval from the Institutional Ethics Committee, a cross-sectional study was carried out among 400 inpatients in a tertiary care hospital in Bangalore. The data were collected from the patient case profile and prescriptions and noted in a self-designed data collection form. The statistical analysis of the collected data was performed using SPSS software and Excel.

Results

The study, conducted on 400 patients, revealed a male majority (60%) and a female representation of 40%. Proton Pump Inhibitors (PPIs), mainly Pantoprazole (74.70%), were frequently prescribed, notably in General Medicine (220 patients). PPI use was generally appropriate: indication (99%), dose (97%), frequency (92.8%), and duration (91.8%). However, irrational prescriptions were noted: indication (1%), dose (3%), frequency (7.3%), and duration (8.3%). 139 drug interactions were identified, categorized into Major (39.6%), Moderate (46%), and Minor (14.4%). For example, Ondansetron and tramadol exhibited a major interaction. Among PPI combinations, 93.75% could affect CYP2C19 metabolism, and 6.3% had additive/synergistic toxicity potential.

Zitieren

APA

Mondal, N., Maity, S., Phawa, A., Roy, B., Kumar, E. S., & V.B, N. S. (2024). A study on appropriate use and stewardship of proton pump inhibitors. Indian Journal of Pharmacy and Pharmacology, 11(1), 56-61. https://doi.org/10.18231/j.ijpp.2024.010

Vancouver

Mondal N, Maity S, Phawa A, Roy B, Kumar ES, V.B NS. A study on appropriate use and stewardship of proton pump inhibitors. Indian Journal of Pharmacy and Pharmacology. 2024;11(1):56-61. doi:10.18231/j.ijpp.2024.010

BibTeX
@article{Mondal2024,
  author = {Mondal, Naresh and Maity, Shilpi and Phawa, Alamki and Roy, Bireswar and Kumar, E. Satheesh and V.B, Narayana Swamy},
  title = {A study on appropriate use and stewardship of proton pump inhibitors},
  journal = {Indian Journal of Pharmacy and Pharmacology},
  year = {2024},
  volume = {11},
  number = {1},
  pages = {56--61},
  doi = {10.18231/j.ijpp.2024.010}
}
Kostenlos starten →